Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;27(4):e575-e578.
doi: 10.1111/hae.14331. Epub 2021 May 13.

Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study

Antonella Coluccia  1 , Emanuela Marchesini  2 , Anna Chiara Giuffrida  3 , Gianna Franca Rivolta  4 , Irene Ricca  5 , Ezio Zanon  6 , Matteo Luciani  7 , Raimondo De Cristofaro  8 , Antonio Coppola  4 , Angiola Rocino  9 ; AICE MECCOVID-19 Study Group
Collaborators, Affiliations

Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study

Antonella Coluccia et al. Haemophilia. 2021 Jul.
No abstract available

Keywords: COVID-19; SARS-CoV-2; congenital bleeding disorders; epidemiology; haemophilia; observational study.

PubMed Disclaimer

Conflict of interest statement

IR acted as a paid consultant to Sobi, Bayer and Takeda/Shire. ACop acted as a paid consultant to Bayer and Novo Nordisk and received fees as an invited speaker by Novo Nordisk, Roche and Werfen. AR acted as paid consultant/member of advisory board/speaker for Bayer, CSL Behring, Kedrion, Novo Nordisk, Roche, Shire/Takeda and Sobi. ACol, EM, ACG, GFR, EZ, ML and RDC had no interests which might be perceived as posing conflict or bias.

References

    1. Coppola A, Tagliaferri A, Rivolta GF, Quinatavalle G, Franchini M. Confronting COVID‐19: issues in hemophilia and congenital bleeding disorders. Semin Thromb Hemost. 2020;46(7):819‐822. - PMC - PubMed
    1. Álvarez‐Román MT, García‐Barcenilla S, Cebanu T, et al. Clinical trials and haemophilia during the COVID‐19 pandemic: Madrid's experience. Haemophilia. 2020;26(5):e247‐e249. - PMC - PubMed
    1. Pipe SW, Kaczmarek R, Srivastava A, Pierce GF, Makris M, Hermans C. Interim guidance; coagulation products safety, supply and access (CPSSA) Committee of the World Federation of Hemophilia. Management of COVID‐19‐associated coagulopathy in persons with haemophilia. Haemophilia. 2021;27(1):41‐48. - PMC - PubMed
    1. Vadasz Z, Brenner B, Toubi E. Immune‐Mediated Coagulopathy in COVID‐19 Infection. Semin Thromb Hemost. 2020;46(7):838‐840. - PMC - PubMed
    1. Coppola A, Lombardi M, Tassoni I, et al. COVID‐19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence. Blood Transfus. 2020;18(3):226‐229. - PMC - PubMed